Mezzion Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17,419	25,574	13,617	40,246	29,399	24,210
Short-Term Investments	-	-	15,000	18,000	3,000	23,284
Cash & Short-Term Investments	17,419	25,574	28,617	58,246	32,399	47,494
Cash Growth	-17.37%	-10.63%	-50.87%	79.78%	-31.78%	-3.28%
Accounts Receivable	939.07	1,078	869.93	2,309	2,644	2,368
Other Receivables	597.07	202.26	457.47	2,154	238.76	377.57
Receivables	2,256	1,990	1,757	5,925	4,203	4,435
Inventory	5,242	5,302	5,420	5,742	8,835	11,777
Prepaid Expenses	227.35	113.77	127.5	136.44	265.05	266.77
Other Current Assets	13,169	12,606	6,004	4,194	195.28	201.3
Total Current Assets	38,313	45,586	41,926	74,244	45,897	64,174
Property, Plant & Equipment	2,382	2,516	2,529	2,854	4,245	4,879
Long-Term Investments	0	0	3.08	7.46	-	-0
Other Intangible Assets	1,620	1,620	1,620	1,620	1,620	1,620
Long-Term Deferred Charges	55,864	47,498	26,820	11,324	-	12,559
Other Long-Term Assets	643.02	694.49	821.1	1,951	1,950	672.93
Total Assets	98,922	98,025	73,998	92,149	54,022	83,935
Accounts Payable	1,819	1,810	1,646	4,030	7,173	5,503
Accrued Expenses	25,213	23,692	18,882	21,831	-	7,188
Short-Term Debt	10,556	9,910	-	499.58	1,063	932.01
Current Portion of Leases	831.99	812.5	694.38	735.87	-	1,051
Current Income Taxes Payable	-	-	3,892	-	-	-
Other Current Liabilities	43,846	43,349	1,556	2,519	17,844	3,823
Total Current Liabilities	82,267	79,572	26,670	29,615	26,080	18,497
Long-Term Leases	1,032	1,151	921.47	1,005	-	2,338
Pension & Post-Retirement Benefits	5.15	-	-	-	-	217.2
Long-Term Deferred Tax Liabilities	-	-	251.42	-	-	-
Other Long-Term Liabilities	106.98	106.62	91.98	84.61	1,702	89.78
Total Liabilities	83,411	80,830	27,935	30,705	27,782	21,141
Common Stock	15,196	15,182	14,982	14,804	13,371	4,451
Additional Paid-In Capital	174,622	173,602	159,062	150,510	99,256	107,802
Retained Earnings	-183,459	-178,129	-143,148	-123,723	-111,052	-74,789
Comprehensive Income & Other	9,151	6,539	15,167	19,854	24,665	25,330
Shareholders' Equity	15,511	17,195	46,063	61,444	26,240	62,793
Total Liabilities & Equity	98,922	98,025	73,998	92,149	54,022	83,935
Total Debt	12,421	11,873	1,616	2,241	1,063	4,321
Net Cash (Debt)	4,998	13,701	27,001	56,006	31,336	43,173
Net Cash Growth	-74.50%	-49.26%	-51.79%	78.73%	-27.42%	-1.88%
Net Cash Per Share	165.52	454.88	905.27	1983.28	1172.20	1617.75
Filing Date Shares Outstanding	30.39	30.36	29.96	29.61	26.74	26.7
Total Common Shares Outstanding	30.39	30.36	29.96	29.61	26.74	26.7
Working Capital	-43,953	-33,987	15,255	44,628	19,817	45,678
Book Value Per Share	510.36	566.28	1537.30	2075.31	981.23	2351.55
Tangible Book Value	13,891	15,575	44,443	59,825	24,620	61,174
Tangible Book Value Per Share	457.07	512.94	1483.24	2020.60	920.66	2290.89
Buildings	-	-	-	-	23.97	23.97
Machinery	-	2,183	2,191	1,976	3,523	2,908
Construction In Progress	-	-	-	619.69	439.17	193.43